Non-opioid Pain Patch Market by Patch Type (Capsaicin Patches, Lidocaine Patches, Diclofenac Patches, Ketoprofen Patches, Methyl Salicylate Patches, and Others) and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies & Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

Pharmaceuticals	LI_183614	Pages: NA	Jun 2019 \| 1156 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

There are a large number of people using opioid medication as painkillers. As per the statistics by the United Nations Office on Drugs and Crime, almost 26.4 to 36 million people abused opioid globally in 2012. Due to an increase in the rate of addiction and severe side-effects associated with the prolonged use of opioid medication there has been an increased demand for the use of non-opioid therapeutics. The mode of action of non-opioid medications are analgesic, antipyretic, and anti-inflammatory. These medications decrease the development of pain mediators in the peripheral nervous system by preventing the enzyme cyclooxygenase at the site of injury, which in turn blocks the production of prostaglandins.

The rise in the incidence of pain disorders has increased the demand for different approaches for pain management. In addition, an increase in costs-associated with the treatment and growing number of people with chronic and acute pain are some of the major driving factors for the market growth. Moreover, the growing awareness regarding the side-effects related with frequent opioid use has further boosted the demand for non-opioid medication. A rise in the abuse of opioid medication has also increased the R&D to develop non-opioid medication, which will further fuel the market growth. However, side-effects with prolonged and excessive use of non-opioid medication such as damage to the liver or kidneys can hamper the market growth.

The global non-opioid pain patch market is segmented based on patch type, distribution, and geography. Based on patch type, the market is segmented into capsaicin patches, lidocaine patches, diclofenac patches, ketoprofen patches, methyl salicylate patches, and others. Based on distribution channels, the market is categorized into hospital pharmacies, online pharmacies, independent pharmacies, and drug stores. Based on geography, the market has been examined across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Teikoku Seiyaku Co., Ltd., Mylan N.V., GlaxoSmithKline plc, Teh Seng Pharmaceutical Mfg. Co., Ltd., Allergan, Pfizer, Inc., Hisamitsu Pharmaceutical Co. Inc., Acorda Therapeutics, and IBSA Institut Biochimque SA, Inc. have also been provided in this report.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global market.
This report entails a detailed quantitative analysis of the current market and estimations from 2017-2023, which assists in identifying prevailing market opportunities.
The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
Competitive intelligence (of leading manufacturers and distributors of non-opioid pain patches) helps understand the competitive scenario globally.
An in-depth analysis of current research and clinical developments within the market has been provided with key market dynamic factors that help understand the behavior of the market.

Non-opioid Pain Patch Market Key Segments:

By Patch Type

Capsaicin Patches
Lidocaine Patches
Diclofenac Patches
Ketoprofen Patches
Methyl Salicylate Patches
Others

By Distribution Channel

Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 NON-OPIOID PAIN PATCH MARKET, BY PATCH TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CAPSAICIN PATCHES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. LIDOCAINE PATCHES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. DICLOFENAC PATCHES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. KETOPROFEN PATCHES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. METHYL SALICYLATE PATCHES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHERS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 NON-OPIOID PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITAL PHARMACIES

5.2.1. Market size and forecast

5.3. ONLINE PHARMACIES

5.3.1. Market size and forecast

5.4. INDEPENDENT PHARMACIES & DRUG STORES

5.4.1. Market size and forecast

Chapter: 6 NON-OPIOID PAIN PATCH MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Non-opioid Pain Patch Market by Patch Type
6.2.5. North America Non-opioid Pain Patch Market by Distribution Channel

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Non-opioid Pain Patch Market by Patch Type
6.3.5. Europe Non-opioid Pain Patch Market by Distribution Channel

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Non-opioid Pain Patch Market by Patch Type
6.4.5. Asia-Pacific Non-opioid Pain Patch Market by Distribution Channel

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Non-opioid Pain Patch Market by Patch Type
6.5.5. LAMEA Non-opioid Pain Patch Market by Distribution Channel

Chapter: 7 COMPANY PROFILES

7.1. TEIKOKU SEIYAKU CO., LTD.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. MYLAN N.V.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. GLAXOSMITHKLINE PLC

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. TEH SENG PHARMACEUTICAL MFG. CO., LTD.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ALLERGAN

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. PFIZER, INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. HISAMITSU PHARMACEUTICAL CO. INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. ACORDA THERAPEUTICS

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. IBSA INSTITUT BIOCHIMQUE SA, INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Non-opioid Pain Patch Market Key Segments:

By Patch Type

By Distribution Channel

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept